awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33771405-D905F4BA-7CB5-41F8-894F-8665A06BD0B1
Q33771405-D905F4BA-7CB5-41F8-894F-8665A06BD0B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33771405-D905F4BA-7CB5-41F8-894F-8665A06BD0B1
Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.
P2860
Q33771405-D905F4BA-7CB5-41F8-894F-8665A06BD0B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33771405-D905F4BA-7CB5-41F8-894F-8665A06BD0B1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1eca15837a01996785eebcf59490f32861d0049
P2860
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.